Gen-Probe (GPRO) volatility elevated after on sharp sell off

Gen-Probe (Nasdaq: GPRO) Madison Williams maintains their Accumulate rating buy lower their price target to $85 from $90 following the shares selling off on June 6th WSJ headlines that said Novartis (NYSE: NVS) appears to be the last remaining bidder for Gen-Probe and it may still walk away from a potential acquisition. Overall option implied volatility of 42 is above its six-month average of 27 according to Track Data, suggesting larger price movement.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• RH (RH) call put ratio 2.1 calls to 1 put with a focus on June 12 weekly 165 calls into quarter results
• GSK (GSK) call put ratio 1 call to 3.5 with a focus on June 50 puts active
• Apple (AAPL) call put ratio 1.4 calls to 1 put amid WWDC 2026